Financials

  • Market Capitalization 151.1 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.59
ratio cours/chiffre d'affaires
34.34

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3737
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.62 USD-1.59%-1.59%-35.42%+50.30%150.94 M USD
3738
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.14 USD-0.87%-0.87%-13.64%-40.00%151.90 M USD
3749
ADCT
ADC Therapeutics SA Common Shares
1.16 USD-0.85%+18.37%+8.41%-62.46%148.09 M USD
3764
UNCY
Unicycive Therapeutics, Inc. - Common Stock
5.07 USD-2.50%-7.31%+1.40%-22.12%141.23 M USD

Nouvelles